These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25964862)

  • 21. The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival.
    Santegoets SJAM; de Groot AF; Dijkgraaf EM; Simões AMC; van der Noord VE; van Ham JJ; Welters MJP; Kroep JR; van der Burg SH
    Oncoimmunology; 2018; 7(8):e1465166. PubMed ID: 30221063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression.
    Vermeij R; de Bock GH; Leffers N; Ten Hoor KA; Schulze U; Hollema H; van der Burg SH; van der Zee AG; Daemen T; Nijman HW
    J Immunother; 2011; 34(6):516-23. PubMed ID: 21654520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer.
    Isobe A; Sawada K; Kinose Y; Ohyagi-Hara C; Nakatsuka E; Makino H; Ogura T; Mizuno T; Suzuki N; Morii E; Nakamura K; Sawada I; Toda A; Hashimoto K; Mabuchi S; Ohta T; Morishige K; Kurachi H; Kimura T
    PLoS One; 2015; 10(2):e0118080. PubMed ID: 25658637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The correlation of the expressions of WWOX, LGR5 and vasohibin-1 in epithelial ovarian cancer and their clinical significance.
    Yu L; Mao X; Wu S; Zhou L; Song W; Gong X; Wang D
    Int J Clin Exp Pathol; 2019; 12(1):327-336. PubMed ID: 31933749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
    Alberti C; Pinciroli P; Valeri B; Ferri R; Ditto A; Umezawa K; Sensi M; Canevari S; Tomassetti A
    Oncogene; 2012 Sep; 31(37):4139-49. PubMed ID: 22158046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14
    Spary LK; Salimu J; Webber JP; Clayton A; Mason MD; Tabi Z
    Oncoimmunology; 2014 Oct; 3(9):e955331. PubMed ID: 25941611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
    Huo J; Hu J; Liu G; Cui Y; Ju Y
    Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
    Tomsová M; Melichar B; Sedláková I; Steiner I
    Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.
    Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A
    Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
    Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953
    [No Abstract]   [Full Text] [Related]  

  • 31. CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment.
    Zhu Y; Zhang Z; Jiang Z; Liu Y; Zhou J
    Front Genet; 2020; 11():369. PubMed ID: 32425977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
    Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
    Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High mRNA expression level of IL-6R was associated with better prognosis for patients with ovarian cancer: a pooled meta-analysis.
    Chen Q; Xu B; Lan L; Yang D; Yang M; Jiang J; Lu B; Shen Y
    Sci Rep; 2017 Aug; 7(1):8769. PubMed ID: 28821817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.
    Tong X; Barbour M; Hou K; Gao C; Cao S; Zheng J; Zhao Y; Mu R; Jiang HR
    Mol Oncol; 2016 Jan; 10(1):113-25. PubMed ID: 26433471
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Yokomizo R; Yanaihara N; Yamaguchi N; Saito M; Kawabata A; Takahashi K; Takenaka M; Yamada K; Shapiro JS; Okamoto A
    Oncotarget; 2019 Aug; 10(47):4880-4893. PubMed ID: 31448054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer.
    De La Motte Rouge T; Corné J; Cauchois A; Le Boulch M; Poupon C; Henno S; Rioux-Leclercq N; Le Pabic E; Laviolle B; Catros V; Levêque J; Fautrel A; Le Gallo M; Legembre P; Lavoué V
    Mol Cancer Res; 2019 Dec; 17(12):2537-2548. PubMed ID: 31537619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B7-H7 is a prognostic biomarker in epithelial ovarian cancer.
    Fu Y; Ding Y; Liu J; Zheng X; Wei W; Ying Y; Wu C; Jiang J; Ju J
    Transl Cancer Res; 2020 Sep; 9(9):5360-5370. PubMed ID: 35117901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
    Zhu Q; Wu X; Wu Y; Wang X
    Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
    Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
    J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.